Histatin-5 vs PACAP-27
Head-to-head comparison of Histatin-5 (Human histatin 5) and PACAP-27 (Pituitary Adenylate Cyclase-Activating Polypeptide-27) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Histatin-5 | PACAP-27 |
|---|---|---|
| Category | Dental & Oral | Diabetes & Metabolic |
| Full Name | Human histatin 5 | Pituitary Adenylate Cyclase-Activating Polypeptide-27 |
| Molecular Weight | 3035 Da | 3158 Da |
| Half-Life | minutes in saliva | minutes |
| Amino Acids | 24 | 27 |
| Typical Dose | 1-100 µM in research formulations | Research-only: 0.1-1 nmol/kg |
| Route | Topical/Oral rinse | Intraperitoneal/Subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 120 | 220 |
| Research Status | Pre-clinical | Pre-clinical |
Histatin-5 Benefits
- ✓anti-Candida activity
- ✓biofilm suppression
- ✓mucosal wound support
- ✓oral innate immunity
PACAP-27 Benefits
- ✓anti-apoptotic signaling
- ✓insulin secretagogue effect
- ✓reduced ER stress
- ✓islet cytoprotection
Histatin-5 Dosing
topical rinse or gel|short contact exposure|repeat applications in research protocols
PACAP-27 Dosing
0.1-1 nmol/kg in animal studies|10-100 nM in vitro|research-only intermittent dosing
Histatin-5 Side Effects
- ⚠local irritation
- ⚠proteolytic instability
- ⚠dose-dependent cytotoxicity in vitro
PACAP-27 Side Effects
- ⚠flushing
- ⚠hypotension at high exposure
- ⚠headache
Research Overview
Histatin-5
Histatin-5 is a major salivary defense peptide that can kill Candida species and influence oral microbial communities. It is also investigated for wound-healing and xerostomia-associated oral infection models.
PACAP-27
PACAP-27 has been repeatedly shown to support beta-cell survival through cAMP/PKA and related pathways. In experimental models it mitigates cytokine damage, preserves insulin content, and helps maintain islet viability.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.